Use of Immunohistochemistry in Melanocytic Lesions
Overview
Authors
Affiliations
The great majority of cutaneous melanocytic lesions can be readily classified as one of the defined diagnostic entities, either benign or malignant. Therefore, only in a minority of lesions, it is necessary to employ ancillary techniques to help in the diagnosis. The most popular and probably the most helpful of these is immunohistochemistry: an area in which Dr McNutt has made some of his most important scholarly contributions. Following Dr McNutt's lead, in this article, we describe the use of immunohistochemistry as a diagnostic aid in dermatopathology as well as the potential pitfalls commonly encountered in practice.
Benign Nevi Mimicking Melanoma: A Diagnostic Dilemma.
Tabassum A, Iqbal M Cureus. 2024; 16(11):e74821.
PMID: 39618769 PMC: 11607779. DOI: 10.7759/cureus.74821.
Ricci C, Dika E, Ambrosi F, Lambertini M, Veronesi G, Barbara C Int J Mol Sci. 2022; 23(11).
PMID: 35682589 PMC: 9180684. DOI: 10.3390/ijms23115911.
The Interplay between Tumour Microenvironment Components in Malignant Melanoma.
Amalinei C, Grigoras A, Lozneanu L, Caruntu I, Giusca S, Balan R Medicina (Kaunas). 2022; 58(3).
PMID: 35334544 PMC: 8953474. DOI: 10.3390/medicina58030365.
Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities.
Hessler M, Jalilian E, Xu Q, Reddy S, Horton L, Elkin K Int J Mol Sci. 2020; 21(24).
PMID: 33339193 PMC: 7765677. DOI: 10.3390/ijms21249583.
A Melanin bleaching method to prevent non-specific immunostaining of chicken feathers.
Nazir S, Charlesworth R, Walkden-Brown S, Gerber P MethodsX. 2020; 7:100957.
PMID: 32612940 PMC: 7317669. DOI: 10.1016/j.mex.2020.100957.